Anonymous
Guest
Anonymous
Guest
Watch, in a few years, Elanco is 60% of revenues and is spun off (like ebay and paypal just split). So, you will have one half making terrifying "animal health" drugs, and the other making insulin which offsets the effects of too much meat consumption.
Everything that is wrong with America, you can find right here.
Good job! Plenty of cash flow, Wall Street is so very happy. What's next, buyout of the high fructose arms of Cargill and ADM?
BRUSSELS (AP) — The European Union's antitrust authority says it has approved the $5.4 billion sale of Novartis' animal health division to U.S. pharmaceutical firm Eli Lilly.
The 28-nation bloc's executive Commission said Friday the sale won't hinder competition because the merged firm will continue to face a number of strong competitors.
Switzerland-based Novartis AG in April launched a major overhaul of its business which included the sale of the animal health division.
Indianapolis-based Eli Lilly & Co. has been hit hard by patent expirations and has staked its recovery in part on new drugs it develops and its animal health business.
Everything that is wrong with America, you can find right here.
Good job! Plenty of cash flow, Wall Street is so very happy. What's next, buyout of the high fructose arms of Cargill and ADM?
BRUSSELS (AP) — The European Union's antitrust authority says it has approved the $5.4 billion sale of Novartis' animal health division to U.S. pharmaceutical firm Eli Lilly.
The 28-nation bloc's executive Commission said Friday the sale won't hinder competition because the merged firm will continue to face a number of strong competitors.
Switzerland-based Novartis AG in April launched a major overhaul of its business which included the sale of the animal health division.
Indianapolis-based Eli Lilly & Co. has been hit hard by patent expirations and has staked its recovery in part on new drugs it develops and its animal health business.